-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-03
TH287 gives cancer researchers a precise way to stress oxidized nucleotide handling before ionizing radiation, with schedule optimization at the center of the workflow. This article translates CRPC findings into practical dosing, DNA-damage assays, troubleshooting steps, and selectivity controls.
-
Cdc42 Targeting in Kidney Fibrosis: Study Insights
2026-09-02
The reference study identifies the natural diterpenoid daphnepedunin A as an anti-fibrotic lead that directly targets Cdc42 and interrupts downstream PKCζ/GSK-3β/β-catenin signaling. Its combination of bioassay-guided discovery, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42-directed strategies in chronic kidney disease.
-
Substance P Workflows for NK-1 Signaling Research
2026-09-02
Build reproducible Substance P experiments for pain transmission research, neuroinflammation, and immune response modulation with a water-compatible peptide workflow. Learn how spectral preprocessing concepts from bioaerosol research can strengthen assay quality control without overstating cross-domain evidence.
-
GW4064 and the FXR–TLR4–Ferroptosis Axis
2026-09-01
GW4064 is a non-steroidal FXR agonist that connects bile acid and lipid regulation with a mechanistically informative LX-2 fibrosis model. This evidence-focused guide explains how to design, interpret, and troubleshoot FXR activation experiments without confusing pharmacological response with therapeutic proof.
-
Mother–Child iPSC Models of MDD and Bipolar Disorder
2026-09-01
This resource study generated and validated two non-integrating human iPSC lines from a mother with major depressive disorder and her son with bipolar disorder. Their familial relationship provides a useful framework for comparing shared and disorder-specific biology while preserving important genetic, sex, and age-related limitations.
-
Biotinylation Maps the CADASIL Neurovascular Interface
2026-08-31
A mechanistic and translational framework for using Sulfo-NHS-Biotin to connect NOTCH3-driven vascular pathology with cell-surface proteomics, cognitive phenotypes, and decision-grade CADASIL model validation.
-
Capsazepine: From TRPV1 Mechanism to Translation
2026-08-31
Capsazepine offers a target-proximal way to dissect TRPV1-driven nociception while exposing important calcium-channel and TRPM8 liabilities. This thought-leadership guide connects rigorous antagonist validation with multidimensional pain models, apoptosis studies, and translational decision-making.
-
Sodium Nitroprusside in Sex-Aware Vascular Assays
2026-08-30
Sodium Nitroprusside is a nitric oxide donor that can function as a mechanistic probe of vascular smooth muscle reserve, not merely a vasodilator. This guide connects its molecular action with the sex-dependent hypertension findings of Xue et al. and translates them into better-controlled vascular and platelet assays.
-
Oligo (dT) 25 Beads: mRNA Workflow
2026-08-29
Oligo (dT) 25 Beads, SKU K1306, provide a magnetic workflow for enriching polyadenylated eukaryotic mRNA from total RNA or animal and plant samples. They are appropriate for polyA-selected mRNA workflows, but not as a universal cleanup reagent for non-polyadenylated RNA, bacterial RNA, or applications requiring unbiased transcript recovery.
-
DAMGO: From Receptor Probe to Pain-Circuit Assay
2026-08-28
DAMGO is a selective µ-opioid receptor agonist for connecting receptor activation with tissue, cellular, and pain-circuit phenotypes. This guide translates recent circuit-level findings into practical assay-selection, control, and interpretation strategies for opioid receptor signaling research.
-
Urolithin A in Mitochondrial Research Workflows
2026-08-28
Urolithin A offers a practical way to connect mitophagy, respiratory function, and metabolic remodeling in cellular assays. This workflow shows how to test its mitochondrial effects alongside glutamine-metabolism endpoints relevant to hepatic stellate-cell and fibrosis research, while avoiding overinterpretation of cross-domain evidence.
-
LY2886721: Practical BACE Inhibitor Workflows
2026-08-27
LY2886721 combines nanomolar BACE1 activity with validated cellular and mouse-model readouts, making it useful for linking amyloid precursor protein processing to functional outcomes. This guide translates those findings into practical assay design, moderate-inhibition strategies, and troubleshooting steps for Alzheimer’s disease treatment research.
-
Fluorescein Tyramide for Oxytocin Circuit Mapping
2026-08-27
Fluorescein Tyramide can sharpen low-abundance molecular readouts in oxytocin and superior colliculus research. This guide connects tyramide signal amplification with the causal findings of a 2026 Communications Biology study while emphasizing assay controls, interpretation, and practical workflow decisions.
-
NSP15 Screening Identifies Thymopentin and Oleuropein
2026-08-26
Vijayan and Gourinath used structure-based virtual screening and molecular dynamics to prioritize natural products against the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein formed the most favorable and stable predicted complexes, providing computational leads for antiviral investigation rather than experimentally confirmed treatments.
-
High-Throughput Discovery of M. tuberculosis DHFR
2026-08-26
Santa Maria et al. developed a data-integration framework that connects whole-cell antibacterial phenotypes with high-throughput protein-binding data and machine learning. The approach recapitulated known mechanisms and prospectively identified nanomolar Mycobacterium tuberculosis dihydrofolate reductase inhibitors, illustrating a practical route for target deconvolution and antibacterial research.